Displaying 10 out of 5 results

  1. New Content Item

    Mylan and Theravance Biopharma's COPD treatment gets FDA approval

  2. FILE PHOTO: A sign is seen at an AstraZeneca site in Macclesfield

    AstraZeneca's drug Fasenra flops in COPD trial

    AstraZeneca's said its first respiratory biologic medicine Fasenra failed to meet its target in a clinical trial treating patients with moderate ...
  3. lung diseases

    Two lung diseases killed 3.6 million in 2015: Study